Victoria J. Johnston

Keppel Street
London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Anti-inflammatory therapy with nebulized dornase alfa for severe COVID-19 pneumonia: a randomized unblinded trial.

Anti-inflammatory therapy with nebulized dornase alfa for severe COVID-19 pneumonia: a randomized unblinded trial.

Journal: eLife

Published: July 15, 2024

British HIV Association guidelines on the management of opportunistic infection in people living with HIV: The clinical investigation and management of pyrexia of unknown origin 2023.

British HIV Association guidelines on the management of opportunistic infection in people living with HIV: The clinical investigation and management of pyrexia of unknown origin 2023.

Journal: HIV medicine

Published: September 20, 2023

Zika virus infection in European travellers returning from Thailand in 2022: A GeoSentinel case series.

Zika virus infection in European travellers returning from Thailand in 2022: A GeoSentinel case series.

Journal: Tropical medicine & international health : TM & IH

Published: June 03, 2023

Bedaquiline as Treatment for Disseminated Nontuberculous Mycobacteria Infection in 2 Patients Co-Infected with HIV.

Bedaquiline as Treatment for Disseminated Nontuberculous Mycobacteria Infection in 2 Patients Co-Infected with HIV.

Journal: Emerging infectious diseases

Published: February 24, 2021

Increased risk of chikungunya infection in travellers to Thailand during ongoing outbreak in tourist areas: cases imported to Europe and the Middle East, early 2019.

Increased risk of chikungunya infection in travellers to Thailand during ongoing outbreak in tourist areas: cases imported to Europe and the Middle East, early 2019.

Journal: Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin

Published: March 14, 2019

Causes and Timing of Mortality and Morbidity Among Late Presenters Starting Antiretroviral Therapy in the REALITY Trial.

Causes and Timing of Mortality and Morbidity Among Late Presenters Starting Antiretroviral Therapy in the REALITY Trial.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Published: March 08, 2018

Fever in the returning traveller.

Fever in the returning traveller.

Journal: BMJ (Clinical research ed.)

Published: January 27, 2018

Assessment of returning travellers with fever.

Assessment of returning travellers with fever.

Journal: Medicine (Abingdon, England : UK ed.)

Published: January 01, 2018

Effectiveness of Protease Inhibitor/Nucleos(t)ide Reverse Transcriptase Inhibitor-Based Second-line Antiretroviral Therapy for the Treatment of Human Immunodeficiency Virus Type 1 Infection in Sub-Saharan Africa: A Systematic Review and Meta-analysis.

Effectiveness of Protease Inhibitor/Nucleos(t)ide Reverse Transcriptase Inhibitor-Based Second-line Antiretroviral Therapy for the Treatment of Human Immunodeficiency Virus Type 1 Infection in Sub-Saharan Africa: A Systematic Review and Meta-analysis.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Published: September 12, 2017

Assessment of returning travellers with fever.

Assessment of returning travellers with fever.

Journal: Medicine (Abingdon, England : UK ed.)

Published: February 01, 2014

Viral suppression following switch to second-line antiretroviral therapy: associations with nucleoside reverse transcriptase inhibitor resistance and subtherapeutic drug concentrations prior to switch.

Viral suppression following switch to second-line antiretroviral therapy: associations with nucleoside reverse transcriptase inhibitor resistance and subtherapeutic drug concentrations prior to switch.

Journal: The Journal of infectious diseases

Published: August 15, 2013

Resistance to tenofovir-based regimens during treatment failure of subtype C HIV-1 in South Africa.

Resistance to tenofovir-based regimens during treatment failure of subtype C HIV-1 in South Africa.

Journal: Antiviral therapy

Published: May 18, 2013

Showing 1-12 of 17

Last Updated: 09/26/2026